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INTRODUCTION 
 
Virpodaga Kuttam is a major skin problem affecting epidermis. The disease is more 
prevalent in the age group of 30 – 40 years, the most economically productive period of the 
individual and causes an enormous socio – economic burden. The pronounced scaling, itching 
hyperpigmentation and cracks also lead to inferior self esteem. It’s more common among people 
of poorer economic status as a result of their high exposure to pollution and chemicals. 
Virpopdaga Kuttam when untreated progress to deformity of bones, protein loss and finally prove 
fatal to the individual. 
 
My aim is to find an effective medicine to cure this disease and to improve the quality of 
life of people suffering from Virpodaga Kuttam. As a post graduate scholar pursuing Siddha 
Medicine I have immense confidence that this disease could be cured by this divine form of 
medicine.  
 
             Siddha system of medical practice is considered a divine art as it is the first system to lay 
its emphasis on inner soul in addition to that of external body. According to Siddha, health is the 
perfect state of physical, psychological, social and spiritual component of a human being. 
 
To quote Thirumoolar, 
              
          “One that cures physical ailment is medicine  
            One that cures psychological ailment is medicine  
            One that prevents ailment is medicine  
            and one that bestows immortality is medicine.” 
 
                   In an effort to demonstrate that the macrocosm is reflected within the microcosm, 
tantra began to emphasize that the universe, in all its totality, is contained within the body of the 
individual. 
 
              The human body is made up of five elements in different combinations. The 
physiological function in the body is mediated by three thathus, which are made up of these five 
elements. They are Vatham, Pitham and Kabam. In each and every cell of the body these three 
doshas co-exist and function harmoniously.  
 
Siddhars classified the diseases in different topics and accounted the total diseases for 
human body as 4448 diseases.  They mentioned about the curable and incurable diseases along 
with the symptoms of the body and predicted the concerned, proper medicines also. 
 
        To cure and prevent diseases the ancient Siddhars described the Siddha system of 
medicine based on panchapootham and three dosha theory.   
 
      The five elements constitute the three doshas and their imbalance causes disease. The three 
doshas are made up of 5 elements. The drugs given for treatment are also made up of the same 
five elements. So by prescribing a drug of the same constituents (guna) the equilibrium is                                      
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 restored. The correction of the imbalance is made by administering the drug which is 
predominately of the opposite nature. 
Mode of action 
 
Siddha Medicine revitalizes and rejuvenates the organs, the dysfunction of which causes 
the disease. This brings back normal functioning of the organs. It also maintains the ratio of 
Vatha, Pitta and Kapha, thus maintaining the healthy state of the body. 
 
        In Siddha system, Siddhars described the skin diseases under the name “Kuttam” and also 
explained that main causes for the skin diseases are heredity, stress, strain and venereal 
afflictions. 
 
As no known Siddha medications are available to treat Virpodaga Kuttam as of now, I 
have attempted to find an effective Siddha medication, to cure this disease. 
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AIM AND OBJECTIVES 
 
 Virpodaga kuttam is one among the eighteen kuttam classified by the Siddhar Yugi in 
Yugi 800. It is also classified under the Saathiya Kuttam.  
 
1. The prime objective of the present study is to explore most efficacious, easily available 
and cost effective drug for virpodaga kuttam. 
 
2. The study would involve observation of the action of parangipattai choornam tablet 
internally and kodiveli ver thylam externally for this disease. 
 
3. The aim of the present study on virpodaga kuttam is to collect authentic measures and 
review the ideas mentioned in ancient Siddha literatures. 
 
4. To expose the efficiency of Siddhar’s diagnostic principles. 
 
5. To know the extent of correlation of aetiology, classification, symptomatology, diagnostic 
methods and line of treatment with allopathic system of medicine. 
 
6. To have an idea about the prevalence of virpodaga kutam with reference to age, socio-
economic status, family history, habits and thinaigal. 
 
7. To know how the disease alters the normal conditions of mukkutram, poripulangal, 
udalkattugal, envagai thervugal, neerkuri and neikuri. 
 
8. To make a detailed evaluation of the disease by careful examination of etiology, 
symptoms, complications, treatment and prognosis. 
 
9. To elicit the pharmacological actions and do bio-chemical analysis and toxicity study of 
the trial drug. 
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REVIEW OF LITERATURE 
 
SIDDHA ASPECTS 
 
In Siddha system skin diseases are classified under the name kuttam. Generally kuttam means 
“Group of skin diseases”.  
 
Description of Kuttam by the Siddhar Dhanvanthiri in his literature “Dhanvanthiri Vaithiyam” is 
given below: 
 
 
Fl;l Nehapd; G+h;t &gk; 
 'njhl;Lg; ghh;j;jhy;  efk;  itj;jhy;  NwhypDzh;r;rp njhpahNj 
 nfl;Lr; rhPue;  jbj;jjpw;  fpsWe;  jpdTk; tpuzKkh 
 kl;by; tpah;it thpdk; tU khwpA  tUfpD  KyUk; 
 tpl;L tpsq;F nkhU td;d NkTq;  Fl;lQ;  rPf;fpuNk" 
 
 'epuj;j Tlk;G ruruj;J  neUg;Gg; nghwp gl;lhw; Gz;zha; 
 fWj;Nj ,uj;j kaph;f; $r;ry; fhZq; Fzq;fsp Jthfpw; 
 nghWj;Nj neLehsD  rhpj;Jg; nghq;Fk; tpahjp nad;wwpf  
 kWj;J Kiuj;Njh k`hFl;lk;  tsik  NaOk; GtpkPNj.“ 
 
Loss of sensory function e.g., touch, pricking with nail. 
Erythema or wheal formation all over the body 
Itching and ulceration 
Sweating may occur, if occurs it dries up soon. 
Change in colour of skin 
Burns like ulcer. 
Hyperpigmentation 
 
If these symptoms occur it indicates that Maha Kuttam will attack soon. 
 
CLASSIFICATIONS 
 
Classification by Yugi 
 
     “Kj;jhFq; Fl;le;jhd; gjpndl; Lf;Fk; 
  Kdpahd A+fpehd;  nrhy;yf; Nfsha; 
 Gj;jhFk; Gz;lhpff; Fl;lj;NjhL 
  nghUfpd;w tpw;Nghlff; Fl;lkhFk; 
 gj;jhFk; ghkFl;lk; Nfru Fl;lk; 
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  ghpthd fuz Fl;lk; rpFk Fl;lk; 
 fpj;jhfk; fpUl;zFl;lk; mTJk;gh; Fl;lk; 
  nfbahd kz;lyFl; lKkh nkd;Nd. 
 
 Fl;lkhk; gh;g;ghpr Fl;l NkhL 
  Fbykhk; tprh;r;rPff; Fl;l khFk; 
 tl;lkhk; itahjp Fl;l NkhL 
  kUtyhq;fp BgFl;lQ; rh;k Nttk; 
 jpl;lkhe; NjjpUf; Fl;lNkhL 
  rpj;Jkh Fl;lQ;rh jhU Fl;lk; 
 Jl;lkhQ;  RNtjFl;le; jd;Ndh nlhf;fr; 
  Rak;ghd gjpndl;L Fl;l khr;Nr" 
 
1. Gz;lhPff; Fl;lk; 10. mgughpr Fl;lk; 
2. tpw;Nghlff; Fl;lk; 11. tprh;r;rPf Fl;lk; 
3. ghk Fl;lk;  12. tpghjpf Fl;lk; 
4. fuz Fl;lk; 13. fpBg Fl;lk; 
5. rpFu Fl;lk; 14. rh;kNjt Fl;lk; 
6. frrh;k Fl;lk; 15. Njj;jpUf; Fl;lk; 
7. fpUl;z Fl;lk; 16. rpj;Jkh Fl;lk; 
8. mTJk;gh; Fl;lk; 17. rjhU Fl;lk; 
9. kz;ly Fl;lk; 18. RNtj Fl;lk; 
 
 
Classification by Dhanvanthiri 
 
Fl;lNuhf tiffs; 
    “thjgpj;jr; rpNyw;gdj;jpd; thjNuhfe; jhnddpDk; 
 jPJ Fl;lnkOe; jPUk; Fl;lk; gjpndhd;W 
 NkhJq; Fl;lk; gjpndl;Lld;Nwha itapDw; gtKk; 
 Ngjf; FzKk; tpahjpapd; Kd;gpwf;Fq; FzK Kiug;NgNd” 
          
1. fghy Fl;lk; 10. ghkh Fl;lk; 
2. rh;kPf Fl;lk; 11. fhfee;jp Fl;lk; 
3. KJk;gh Fl;lk;  12. ]pj;kh Fl;lk; 
4. fpBg Fl;lk; 13. tpghjpfh Fl;lk; 
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5. tprh;rpfh Fl;lk; 14. rjhhpf Fl;lk; 
6. kz;lyhf;fpu Fl;lk; 15. tp];Nghlf Fl;lk; 
7. mFit Fl;lk; 16. rh;kjy  Fl;lk; 
8. jj;U Fl;lk; 17. ntz; Fl;lk; 
9. Gz;lhPf Fl;lk; 18. myr Fl;lk; 
 
 
Classification in Anubava Vaithiya Deva Ragasiyam 
 
thjhjp Oki]k<okif ;jNgjj;jpdhy; Fl;lNehahdJ gjpndl;L tifg;gLk;.  mjhtJ 
 
1> thjj;jhy;     fghy Fl;lk; 
 
2. gpj;jj;jhy;    mTJk;gu Fl;lk; 
 
3. rpNyj;Jkj;jhy;   kz;ly Fl;lk;>  
tprh;r;rpf Fl;lk; 
 
4. thj gpj;jjj;jhy;   Urpa [pk;kpf Fl;lk; 
 
5. rpNyj;Jkj;jhy;   rUk Fl;lk;>  
Vf Fl;lk;>  
fpbg Fl;lk;> 
      rpj;k Fl;lk;>  
myr Fl;lk; 
 
6. rpNyj;Jk thjj;jhy;  tpghjpfh Fl;lk; 
 
7. kqiqOki]k<kiz;   jj;JU Fl;lk; 
      Gz;lhPf Fl;lk; 
      rjhU Fl;lk; 
      tp];Nghl Fl;lk; 
      ghkh Fl;lk; 
      rh;kjy Fl;lk; 
      fhfr Fl;lk; 
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 ,tw;Ws; mtJk;guk;> kz;lyk;> Urpa[pk;kpfk;> Gz;lhPfk;> fghyk;> fhfrk; vd;Dk; 
6 Fl;lq;fis kfhFl;lq;fnsd;W $wg;gl;Ls;sJ. 
 
 
AETIOLOGY  (Neha; tUk; top)  
 
 
The aetiology for kuttam was described by various Siddhars in their literatures. The classical 
writing of Siddha system attributes the aetiology of the skin disease to the following  
  
1. Heredity 
2. Stress 
3. Strain 
4. Insect Bite 
5. Worms 
 
Except these no specific causes were mentioned for “Virpodaga Kuttam” 
 
Thirumoolar Karukkadai Vaithiyam 
 
'tpahjpAs; %thW tpsq;fpa Fl;lq;Nfs; 
 Rahjpf; fpue;jp Rod;Nkfj; jhyhWk; 
 gahjp kz;Zsg; gytz;b dhnyl;Lk; 
 epahjpg; GOehyha; epd;wjpf; Fl;lNk" 
 
 
Yugi Vaithya Chinthamani 800 
!
(uqtl<hOu!!lqGf<kd]<  ze;jd;  dhYk; 
  kpFe;jrP  jsj;jhY  kow;rp  ahYk; 
 tsk;gNt  ke;jj;jhy;  the;jp  ahYk; 
  kfj;jhd  ngz;NzhL  kUt  yhYk; 
 fpsk;gNt  fpNyrq;fs;  kpFj  yhYk; 
  nfbahd  th;f;fq;fs  ilj  yhYk; 
 jsk;gNt  kapUfph;fs;  jtpL  kz;fs; 
  rhjj;jpw;   gUf  yhy;  Fl;lk;" 
 
1. Too hot or too cold climatic changes 
2. Indigestion  
3. Illegal sexual contact 
4. Taking food that contains hair, sand etc. 
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Agasthiyar Kanma Kaandam 
 
“Nrh;e;j  Fl;lnkhL  FiwNeha;fs;  te;j 
  Nrjp  Nfs;  kyuhj  tUk;G  nfha;jy; 
 jhhpe;j  rPtnre;J  tijfs;  nra;jy; 
  jha;je;ij  kdJ  nehe;J  Nuhfe;jhNd 
 jhndd;w  nja;tTUj;  jidaopj;jy; 
  rhh;thd  nghpNahh;fs;  jikg; gopj;jy; 
 fhndd;w   ee;jtdk;  G+Q;nrbfs;  ntl;ly; 
  fUkklh  rhPuj;jpw;   fhRNghNy 
 A+ndd;w  Tlk;ngy;yhk;  nkhl;Lg;  nghl;lh  
  Alk;G  ntSj;J  FiwNah  AjpuQ;  rpe;Jk; 
 thndd;w  fUkq;fs;  jPh;g;gjw;F 
  tifnahd;W  nrhy;Ntd;  Nfs;  ee;jtdk;itNa” 
 
 
1. Plucking the unflowered buds 
2. Cruelty to animals 
3. Destroying Statues of Gods 
4. Teasing of older people 
5. Destroying forests and gardens 
 
Guru Naadi Nool 
 
'fpUkpahy;  te;jNjhlk;  ngUf  Tz;L 
  Nfl;fpyjd;   gphptjidf;   fpukkhf 
 nghUkptUk;  thAnty;yhq;  fpUkpahNy   
  GOf;fbNghy;  fhZkJ  fpUkpahNy  
 nrUkptUk;  gTj;jpuq;fs;  fpUkpahNy 
  Njfkjpy;  Nrhiff;  Fl;lq;  fpUkpahNy"... 
 
 'gapy;  nkhopaPh;  jpNufj;jpy;  fpUkpjhNd 
  gue;Jjphp  Fl;lk;Nghy;  Gs;sp  fhZk; 
 kapyJTk;  fpUkpAe;;jh  ele;J  Gf;fpy; 
  NkdpaJ  rurnud  ntbj;Jg;  Gz;zhk;" 
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Dhanvanthiri Vaithiyam 
 
 
'mwptpd;wp  tpghPjQ;  Nruhfhuk;  Grpf;fyhYk; 
Jiwad;wp  njhlhj  njhd;iw  njhl;lit Grpf;fyhYk; 
 Fiwnfhz;l  eprpj;jkhd  Fykq;ifaLf;fyhYk; 
  epiwnfhz;l  nghpNahh;  jk;ik  epe;jpj;Jg; NgryhYk; 
 epe;jpj;J  Gwj;jpahw;  Nrhkepiy  nflg;  gphpf;fyhYk; 
  te;jpj;J  G+Uth  nrd;khe;jpu  ghtj;jhYQ; 
 re;jpf;ff;  fw;G  khjh;   jq;fisf;  fUjyhYk; 
  njhe;jpj;j  Fl;lNuhfe;  njhLf;f  nkd;Wiue;Njhh; Kd;Ndhh;." 
 
Scolding older people. 
Illegal sexual contact 
Having food items which need to be avoided 
Taking together of food items of opposite nature. 
 
 
Maan Murugiyam 
 
 
 
',lk;  nghO  JzT  njhopNyhL  gUtk; 
  vDkpit   NtWgLjyhYk; 
 eQ;R+wy;  eQ;Rf;  fbAW  nghWk; 
  gpzpAw  yhYk;  epwk;   ngah;e;jpLNk." 
         
-  ftpuhr  gz;bj  ,uhkRg;gpukzpa ehtyh; 
 
 
 
Guru Naadi 
 
 
'ey;Nyhh;  nghpNahh;fs;   elj;JQ;  nra;if 
  ehl;bYs;s  K]<l  n[d;kk;  eifj;jhNy 
nghy;yhj uq]g<fbfs;  te;J  Gf;fpg; 
nghd;ikAs;s  Njfnky;yhk;  Fl;lk;  NghNy 
nrhy;yhj  uq]g<gcgt;  uq]g<Ge<ll;  ghz;L 
jPuhj  fd;ktpid  nra;j  ghtk; 
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vy;yhUq;  fhztpJ  Gtpapd;  kPNj 
,zq;fp  te;Nj  gcuq]r<  fhpak;  gyhNk." 
 
 
Poisonous bites 
Teasing old people 
 
Pararasa Sekeram 
 
 
“midty;  tpidapdhNy  nkha;j;njOq;  Fl;lNuhfk; 
  ikNrh;  newpapYa;f;F  ew;wtf;  Fuig  nka;k;ik 
 ld;dpL  kd;gh;  jk;ik  Ajhrpdk;  Ngrp  ehSk; 
  ,d;dy;  nra;ghj  fj;Njhh;f;  nfa;jpLnkd;Dk; 
 NtjNk  Aiuf;F  Nkyh  newpapdpy;  tpyfp  ehSk; 
  VjNk  GhpAe;  jPNahh;f;  nfa;Jt  jg;ghd;  NkNyhh; 
 Xjpa  newpap  dpd;Nw  Aaph;fSf;  FWjp  nra;Ak; 
  khjth;  jk;ik  ae;Neha;  tUj;j  ehq;  fz;bNyhNk 
 MdNjhh;  thjgpj;j  Nrw;gd  kjdpdhYk; 
  khddha;  tpleP  uhYkq;ifah;  tUj;jj;jhYk; 
 <dkhq;  fpue;jpahY  kpopTW  Fl;lNuhfk; 
  jhdkpy;  yhNj  rhUnkdKdp  rhw;wp  dhNd.” 
 
 
Agasthiyar Vaithiyam 
 
'Fay;tha;  Fl;lk;  raq;Fd;k  ePhpopT  Ruf;fpuhzp 
  ePuilg;G  ghz;L  %ytha;T 
 fay;thA  tUq;fz;zpy;  Fj;jha;  foe;  jrtha;T 
  fhzthf  Kd; nra;j  caph;fSk;  tpidjhNd. ” 
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PATHOLOGY (Fl;lNuhfk;  rk;gtpf;Fk;  tpjk; ) 
 
Dhanvanthiri 
 
“Kd;dpNa  thjgpj;jr;  rpNyj;kd  %d;W  kq;fk; 
 gpd;dpNa  jWf;fhAs;s  euk;gpdpw;  gpuNtrpj;J 
 kd;dpa  ,uj;je;  jz;zPh;  khq<gq]f<  Njhy;  nfLj;Nj 
 ad;dpa  td;dq;  fhZ  khifahw;  Fl;lkhNk.” 
 
    - thjk;> gpj;jk;> fgk; ,k;%d;Wk; Nfhshwile;J euk;gpy; Nrh;e;J ,uj;jk;> jz;zPh;> 
khkprk;> Njhy; Kjyhditfisf; nfLj;J th;z khWghLfis cz;lhf;Fk;. 
 
Theraiyar 
  
'thjkyhJ Nkdp  nflhJ" 
     -  vd Njiuah; 
 
Thiruvalluvar 
 
'kpfpDq;  FiwapD  Neha;nra;Ak;  E}Nyhh; 
 tsp Kjyh ntz;zpa %d;W". 
 
 
Mukkutram    (Kf;Fw;w ,yf;fzk;) 
 
 ,r;rhPuk;  gpUjptp  vd;Dk;  G+jj;jhy; cUthfp> Mfhak; vd;Dk; G+jj;jpdplkhf 
xLq;fp mg;G> NjA> thA vd;Dk; %d;W G+jq;fshy; ,af;fg;gl;L tUfpd;wJ. 
 Nkw;$wg;gl;l mg;G> NjA> thA vd;gNj fg> gpj;j> thjnkd;w Kf;Fw;wq;fnsdTk;> 
,itfspd; ,af;fj;jpd; tpfw;gNk Neha;f;F fhuznkdTq;  $wg;gLk;. 
 
The human body is made up of 96 taththuvas, alteration in normal state of any taththuvam results 
in pathological states.  
 
Human body is made up of five boothas, they are  
 
1. Earth 
2. Water 
3. Fire 
4. Air 
5. Ether  
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Bone, skin, muscle, hair and nerve are constituted by the bootham earth and any change in this 
bootham will cause disease in these structures. 
  
Yugi classified kuttam into eighteen types. Virpodaga kuttam is one among the eighteen 
types of kuttam. 
 
tpw;Nghlf  Fl;lk; 
 
  “GJikaha;r;  rhPunkq;Fe;  jpdTz;  lhFk; 
   nghUntbaha;j;  jpf;nfdj;jPf;  nfhOe;J Nghy 
  nkJikaha;  tpl;nlhpAk;  ey;yghk;gpd; 
   uq]h<hml;  NghNy  jbj;J  ntSg;G  khFk; 
  RJikaha; kpfr;  nrhhpAQ;  rptg;G“khFk; 
   J}f;fnkhL  rQ;ryKk;  kpfTz;  lhFk; 
  fJikaha;  Njhnyy;yhe;  jbg;Gz;lhFk; 
   fdj;jtpw;  Nghlfkhd  Fl;le;jhNd.” 
 
Itching all over the body 
Cracks, 
Burning sensation in skin (Inflamed skin) 
Thickening of skin 
Skin becomes pale 
Erythema 
Insomnia 
 
Dhanvanthiri  
 
tpw;;Nghl  Fl;lf; Fwpfs; 
 
  “mq;f  gq;fq;fshfg;  gpope;jpL  kq;fnky;yhk; 
  Jq;fNt  jidAe;  jPUk;  Njhd;wpL  kpit  tpw;;Nghlk; 
  gq;fa  Kifia  ntd;Nw  ahlth;  kU (kk;gh) ae;J 
  Fq;Fkq;  fsgk;  G+Rq;  FQ;ruf  nfhq;if khNj.” 
 
   
Cracks all over the body 
Itching and pain 
Blisters formation 
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Anubava Vaithiya Deva Ragasiyam 
 
 
tp];Nghl Fl;lk; 
 
 nfhg;Gsq;fs; rpte;Jk;,  ntSj;Jk;,  tp];jhpj;J vOk;gp; tpuzq;fshfp  mjpy; 
jpdT, vhpr;ry; cz;lhjy; rUkk; kpUJthf  ,Uj;jy;> uq]obiqs<sz ;  nahj;j vhpr;ry;> 
ntspwy; vd;Dk; Fzq;fSilaJ.  
 
 
DIAGNOSIS 
 
Diagnosis is mainly done by  
 
Signs and symptoms 
Envagai Thervugal 
Udal thathukkal 
 
The presence of following signs and symptoms confirm diagnosis 
 
1. Itching  
2. Scaling 
3. Erythema 
4. Cracks 
5. Pain and burning sensation 
6. Cold intolerance 
7. Insomnia 
8. Hyperpigmentation 
9. Thickening of skin 
10. Malaise 
 
Envagai Thervugal 
 
Siddhars have developed a unique method of diagnosing the disease by envagai thervugal.  
 
By maruthuva nool vallor 
 
       “fic!];ghprk; ehepwk; olipq!uqpq!!
!!! !!lzl<!&k<kqvlqju!lVk<KuviBkl<”!
!
 
Naa – Pallor, glossy, ulcerated 
Niram – Hypopigmentation or hyperpigmentation of the skin 
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Mozhi – Speech interrupted or irrelevant 
Vizhi – pallor, vision - impaired 
Sparism – warm, cold, rough or smooth on touch 
Malam – Constipation or diarrhea  
Moothiram –  
Neerkuri – smell, colour, froth and sediments 
Neikuri – Study by using gingely oil 
Naadi –  
 
Udal Thathukkal 
 
Saram – gives strength to body and mind 
Cheneer – responsible for knowledge, strength, boldness, healthy complexion 
Oon – gives structure and shape to body and is responsible for movements of the body 
Kozhuppu – Lubricates the internal organs and helps the organs to work smoothly. 
Enbu – Protects the vital organs and used for movements and nominates body structure. 
Moolai – present inside the bones and it gives strength and maintains the normal 
   condition of the bone 
Sukkilam/Suronitham – responsible for reproductive function of species  
 
 
CURABLE, NON-CURABLE KUTTAM   
 
 rhj;jpah, mrhj;jpa Fl;l Neha; 
 
Classification by Yugi 
 
rhj;jpak;  
“Fl;le;jhd;  gjpndl;by;  rhj;jp ae;jhd; 
   $wf;Nfs;  tpw;Nghlf  gukk;w; Fl;lk; 
  fpl;le;jhd;  Nfr;rh;k  Fll NkhL 
   fpUl;z  Fl;lk  TJk;gh;  Fl;le; jhDk; 
jpl;lkhe;  Njj;jpUf;  Fl;l NkhL 
   nrarpj;J khFl;lq;  fpBg  Fl;lk; 
  jl;mf<kie<!!lqGf<ksi!!kiV!!Gm<ml<!
! ! ! rkfpUl;z  Fl;lkrhj;  jpakh  nkd;Nd. ”  
 
mrhj;jpak; 
  ”Mnkd;w gj;Je;jhd;  rhj;a  khFk; 
   mrhj;akJ  jhndl;L  mwpe;J  ghU 
  Nghnkd;w  G+h;tj;jpd;  fd;kj;  jhYk; 
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   Gtpjdf;Fk;  kpFfd;kQ;  nra;j  ghtk;  
  ghnkd;w  nghpNahh;fs;  rhgj;  jhYk; 
   ghjq;fs;  kdjwpag;  gz;Zk;  Ngh;f;Fk; 
  Nfhnkd;w Fl;lkhk;  Nuhfk;  te;J 
   $Lnkd;W  A+fpKdp  $wpNdNd. ” 
 
Classification by Dhanvanthiri 
 
mrhj;jpa  Fl;lk; - 7 
 
     “nrhy;Yq; F]<ml< vOtifNgh;  nrhy;ypw;  fghyQ;rh;kPfk; 
  nty;Y  KJk;gh  Nkfpbgk;  tprh;r;rp  kz;lyhf;fpuK 
  ky;yy;  jUk;rp  aFit  ahFk;  ngaNuh NuohFk; 
  ty;ytpahjpf;  Fzkjid  tFj;Jg;  ghhpYiug;NgNd’. 
 
1. fghy Fl;lk; 
2. rh;kPf Fl;lk; 
3. KJk;gh Fl;lk; (mTJk;gu Fl;lk;) 
4. fpBg Fl;lk; 
5. tprh;rpfh Fl;lk; 
6. kz;lyhf;fpu Fl;lk; 
7. RFit Fl;lk; 
 
rhj;ak;  gjpndhd;wpd;  ngah; 
 
  “G+z;ljj;  JUtpNdhL  rjhhpfk;  Gz;lhPfe; 
  jhz;L tpw;Nghlk;  ghkh Tld; rh;kjyk; ntz;Fl;lq; 
  $z;bL  fhfee;jp  rpj;Jik  ayr  F\;lk; 
  Ntz;ba  tpthjpNahLk; gjpndhd;Wk;  tphpj;Jf; fhNz” 
 
1 jj;U Fl;lk; 
2 rjhhpff;  Fl;lk 
3 Gz;lhPf Fl;lk; 
4 Tp];Nghlff; Fl;lk; 
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5 ghkh Fl;lk 
6 rd;kjyk;  Fl;lk;  
7 fhfee;jp Fl;lk;  
8 ntz; Fl;lk; 
9 ]pj;kh Fl;lk;  
10 myrk;  
11 tpghjpfh Fl;lk;  
 
G]<m!Ovig!hk<kqbr<gt<!
 hjpb!bukieqbl<!
!
 OgiKjl?!hs<js!hbX?!sl<hi!niqsq?!Kujv?!sqXgmjz?!Oke<?! Ohb<h<Hmz<?!
g{<mr<gk<kqiqh<hpl<?! l{k<kg<gitq?! Ouh<h-jz?! out<jth<H,{<M?!
out<jts<sivj{?!gMg<gib<H,?! kvi!-jz?! Osvir<ogim<jm!hpl<?! hel<hpl<?!
gVr<gizq?! sqk<kqv&zl<?! kqiqhjz?! \ikqg<gib<?! sqXfigh<H,?! Gr<Glh<H,?!
hjpbofb<?! hQi<g<gr<gib<?! niqsq?! out<jtg<gMG?! ne<el<?! OkukiV?!
nOsigl<?! ngV! -jugtqe<! jkzr<gt<?! g <^K~iq?! sf<kel<?! gsh<H!
hkii<k<<kr<gt<?! ]ivr<gt<! -jugt<! biUl<?! Oki]k<kqe<! hzihze<gjt!
nxqk<K!G]<mOvigk<kqx<G!hk<kqblqmOu{<Ml</!
!
!
nhk<kqbl<!
!
! Htqh<H?!dh<H?!givr<gt<!-jugTme<!%cb!ne<ehier<gt<?!kbqi<?!hiz<?!ouz<zl<?!
wt<T?! dTf<K?! uqbi<ju! uir<Gkz<?! liki<H{i<s<sq?! uif<kq! Ougk<jkk<! kMk<kz<?!
gVl<Hvsl<?! \zk<kqzqVg<Gl<! \f<Klilqsl<?! kbqi<,! gt<! -jugjt! Gm<mOvigqgt<!
uqmOu{<cbK/!
!
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MODERN ASPECTS 
 
 
            The skin is a vital organ that covers the entire outside of the body, forming a protective 
barrier against pathogens and injuries from the environment. The skin is the body's largest organ; 
covering the entire outside of the body, it is about 2 mm thick and weighs approximately six 
pounds. It shields the body against heat, light, injury, and infection. The skin also helps in 
regulating body temperature, gathering sensory information from the environment and stores 
water, fat, and vitamin D, and plays a role in the immune system protecting us from disease. 
 
           The structure of skin varies from site to site of the body. There are two general types of 
skin; thin and hairy, which is more prevalent on the body, and thick and hairless, which is found 
on parts of the body that are used heavily and endure a large amount of friction, like the palms of 
the hands or the soles of the feet. 
            Basically, the skin is comprised of two layers that cover a third fatty layer. These three 
layers differ in function, thickness, and strength. The outer layer is called the epidermis; it is a 
tough protective layer that contains the melanin-producing melanocytes. The second layer 
(located under the epidermis) is called the dermis; it contains nerve endings, sweat glands, oil 
glands, and hair follicles. Under these two skin layers is a fatty layer of subcutaneous tissue, 
known as the subcutis or hypodermis. 
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The skin contains many specialized cells and structures: 
Basket Cells – Basket cells surround the base of hair follicles and can sense pressure. They are 
evaluated when assessing overall nerve health and condition. 
Blood Vessels – Blood vessels carry nutrients and oxygen-rich blood to the cells that make up the 
layers of skin and carry away waste products.  
Hair Erector Muscle (Erector Pili Muscle) – The erector pili muscle is a tiny muscle connected to 
each hair follicle and the skin. When it contracts it causes the hair to stand erect, and a "goose 
bump" forms on the skin. 
Hair Follicle – The hair follicle is a tube-shaped sheath that surrounds the part of the hair that is 
under the skin and nourishes the hair. It is located in the epidermis and the dermis.  
Hair Shaft - The hair shaft is the part of the hair that is above the skin. 
Langerhan’s Cells - These cells attach themselves to antigens that invade damaged skin and alert 
the immune system to their presence. 
Melanocyte – A melanocyte is a cell that produces melanin, and is located in the basal layer of 
the epidermis. 
Merkel Cells – Merkel cells are tactile cells of neuroectodermal origin located in the basal layer 
of the epidermis.  
Pacinian corpuscle – A pacinian corpuscle is a nerve receptor located in the subcutaneous fatty 
tissue that responds to pressure and vibration.  
Sebaceous Gland - Sebaceous glands are small, sack-shaped glands which release an oily 
substance onto the hair follicle that coats and protects the hair shaft from becoming brittle. These 
glands are located in the dermis. 
Sensory Nerves – The epidermis is innervated with sensory nerves. These nerves sense and 
transmit heat, pain, and other noxious sensations. When they are not functioning properly 
sensations such as numbness, pins-and-needles, pain, tingling, or burning may be felt. When 
evaluating a skin biopsy, total number, contiguity, diameter, branching, swelling, and overall 
health of the sensory nerves are assessed. 
Sweat Gland (Sudoriferous Gland) - These glands are located in the epidermis and produce 
moisture (sweat) that is secreted through tiny ducts onto the surface of the skin (stratum 
corneum). When sweat evaporates, skin temperature is lowered. 
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                The epidermis, the topmost layer of the skin, is only 0.1 to 1.5 millimeter thick. It is 
made up of five layers: the basal cell layer, the squamous cell layer, the stratum granulosum, the 
stratum lucidum, and the stratum corneum. Working together, these layers continually rebuild the 
surface of the skin from within, maintaining the skin’s strength and helping thwart wear and tear. 
 
                The process begins in the basal cell layer, the innermost layer of the epidermis. This 
layer houses small round cells called basal cells. These cells constantly divide, with the new cells 
constantly pushing older ones on a migration toward the surface of the skin. The basal cell layer 
is also called the stratum germinativum because it is constantly producing, or germinating, new 
cells. 
 
                The basal cell layer also contains melanocytes, specialized cells that produce a pigment 
called melanin. Melanin protects the skin against sun damage, and its rate of production 
determines skin color—the more melanin produced in the skin, the darker the skin appears. 
Exposure to the sun causes the melanocytes to increase melanin production in an effort to shield 
the skin from damaging ultraviolet rays; the resulting effect is a suntan. Freckles, birthmarks, and 
age spots are also caused by patches of melanin within the skin. 
Above the basal cell layer is the squamous cell layer, also called the stratum spinosum or “spiny 
layer” because the cells are held together with spiny projections. Here lie the basal cells that have 
been pushed upward; these maturing cells are now called squamous cells, or keratinocytes. They 
have begun to produce keratin, a tough, protective protein that makes up a large part of the 
structure of the skin, hair, and nails. (Horses’ hooves, fish scales, and animal horns are also made 
of keratin.) 
 
                The squamous cell layer is the thickest layer of the epidermis. This is the layer of the 
skin that helps to move certain substances in and out of the body; it’s also where blisters form 
when the skin is chaffed. The squamous cell layer also contains cells called Langerhans cells. If 
the skin becomes damaged, these cells latch onto invading antigens, substances that are foreign to 
the body, and alert the immune system to their presence. 
 
               The keratinocytes from the squamous layer are then pushed up through two thin 
epidermal layers called the stratum granulosum and the stratum lucidum. As the cells migrate, 
they enlarge, flatten, and bind together, then eventually become dehydrated and die. The process 
fuses the cells into layers of tough, durable material, which continue to rise toward the skin’s 
surface. 
 
               As the layers near the surface, they become part of the stratum corneum, the outermost, 
visible layer of the epidermis. The stratum corneum (or “horny layer,” because its cells are 
toughened like an animal’s horn) is made up of 10 to 30 thin layers of these dead cells. External 
pressure or friction can cause thickened areas in the stratum corneum known as corns or calluses. 
 
              As the outermost cells give way to wear and tear, they are replaced from within by new 
layers of strong, long-wearing cells. In the average adult, it takes nearly a month for the stratum 
corneum to be completely replaced. The replacement process generally slows with age, though in 
some people it becomes abnormally accelerated, causing a flaky, scaly skin condition known as 
psoriasis. 
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Most of the features of Virpodaga Kuttam can be correlated to exfoliative dermatitis  
 
GENERALISED EXFOLIATIVE DERMATITIS 
 
Generalized exfoliative dermatitis (erythroderma) is severe inflammation that causes the 
entire skin surface to become red, cracked, and covered with scales.  
 
Symptoms and Diagnosis 
 
Exfoliative dermatitis may start rapidly or slowly. At first the entire skin surface becomes 
red and shiny. Then the skin becomes scaly, thickened, and sometimes crusted. Sometimes the 
hair and nails fall out. Some people have itching and swollen lymph nodes. Although many 
people have a fever, they may feel cold and have chills because so much heat is lost through the 
damaged skin. Large amounts of fluid and protein may seep out, and the damaged skin is a poor 
barrier against infection. Because symptoms of exfoliative dermatitis are similar to those of skin 
infection, doctors send samples of skin and blood to the laboratory to exclude infection as a 
cause. 
 
Pathogenesis  
 
Exfoliative dermatitis is the result of a dramatic increase in the epidermal turnover rate. In 
patients with this disorder, the mitotic rate and the absolute number of germinative skin cells are 
higher than normal. Moreover, the time necessary for cells to mature and travel through the 
epidermis is decreased. This compressed maturation process results in an overall greater loss of 
epidermal material, which is manifested clinically as severe scaling and shedding. Normal 
epidermis undergoes some exfoliation every day, but the scales that are lost contain little, if any, 
important viable material, such as nucleic acids, soluble proteins and amino acids. In exfoliative 
dermatitis, however, protein and folate losses may be high. The pathogenesis of exfoliative 
dermatitis is a matter of debate. In recent years, clinicians have come to believe that this 
condition is secondary to a complicated interaction of cytokines and cellular adhesion molecules. 
Interleukin (IL)-1, IL-2, IL-8, intercellular adhesion molecule 1 (ICAM-1), tumor necrosis factor 
and interferon gamma are the cytokines that may have roles in the pathogenensis of exfoliative 
dermatitis.  
 
Etiology  
 
The most common causes of exfoliative dermatitis are preexisting dermatoses, drug reactions, 
malignancies and other miscellaneous or idiopathic disorders. 
 
Dermatoses Associated with Erythroderma  
• Contact dermatitis  
• Ichthyosis  
• Lichen planus  
• Pemphigus  
• Psoriasis  
• Seborrheic dermatitis  
• Vitamin deficiency 
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Laboratory Findings  
 
Laboratory evaluation of patients with erythroderma is generally not very helpful in 
determining a specific diagnosis. Typical laboratory values include mild anemia, leukocytosis, 
eosinophilia, elevated erythrocyte sedimentation rate, abnormal serum protein electrophoresis 
with a polyclonal elevation in the gamma globulin region, and elevated IgE levels. 
 
Blood counts and bone marrow studies may reveal an underlying leukemia. Analyses for 
circulating Sézary cells may be helpful, but only if the cells are identified in unequivocally large 
numbers.  
 
Complications 
 
•  Complications in ED depend on underlying disease. Secondary infection, 
dehydration, electrolyte imbalance, temperature dysregulation, and high-output 
cardiac failure are potential complications in all cases.  
 
Prognosis 
 
• The prognosis of ED depends largely on underlying etiology.  
  
• The disease course is rapid if it results from drug allergy, lymphoma, leukemia, 
contact allergens, or staphylococcal scalded skin syndrome.  
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MATERIALS AND METHODS 
 
The clinical study on Virpodaga kuttam was done in post graduate department of “Sirappu 
Maruthuvam of Ayothidoss Pandithar Hospital attached to National Institute of Siddha at 
Tambaram Sanatorium, Chennai over a period of one year. 
 
1 Selection of cases for the clinical study was based on the presence of following signs and 
symptoms.  
 
1. Itching  
2. Scaling 
3. Erythema 
4. Cracks 
5. Pain and burning sensation 
6. Cold intolerance 
7. Insomnia 
8. Hyperpigmentation 
9. Thickening of skin 
10. Malaise 
 
2 According to the severity they are treated either as out patients or in patients. 
3 On the day of admission routine laboratory investigations, general and systemic 
examinations, neerkuri and neikuri were done. 
4 Patients were treated with internal medicine “Parangipattai Churanam” with “Sivanaar 
Vembu Kuzhi Thylam” and external medicine “Kodiveli Ver Thylam” 
5 All the patients were advised to follow the pathiyam and were advised to visit the out 
patient department for further follow up. 
 
EVALUATION OF CLINICAL PARAMETERS 
 
 During admission the patients were subjected to careful history taking. The history 
collected from patients include 
 
1 Occupation 
2 Dietary habit 
3 Family history 
4 Autoimmune disorders 
5 Diabetes mellitus 
6 Hyper tension 
7 Venereal diseases 
 
 
MODE OF DIAGNOSIS 
 
The diagnosis is done by the following basic Siddha principles. 
 
1 Poriyal Arithal 
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2 Pulanal Arithal 
3 Vinaathal 
 
Physicians’ Pori and Pulan are used as tools for examining the Pori and Pulan of patients. 
 
Poriyal Arithal 
 
Pori denotes the five sense organs, namely 
 
1 Nose 
2 Tongue 
3 Eye 
4 Skin 
5 Ear 
 
Pulanal Arithal 
 
 Pulans are five senses. They are  
 
1 Smell 
2 Taste 
3 Vision 
4 Sensation 
5 Hearing 
 
Vinaathal 
 
 Vinathal is gathering the information regarding the history of diseases, its clinical features 
etc., from the patient or from his close relatives who are taking care of him.  
 
Envagai Thervugal 
 
 It’s a unique method of diagnosing the disease  
Naadi, Sparism, Naa, Niram, Mozhi, Vizhi, Malam, Moothiram 
 
Clinical Assessment 
 
 Itching, scaling and erythema 
 
LABORATORY INVESTIGATIONS 
 
1 Blood tests 
 
a. Haemoglobin 
b. Total Count 
c. Differential Count 
d. Erythrocyte Sedimentation Rate 
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e. Blood Urea 
f. C – Reactive Protein 
g. Serum Creatinine 
h. Blood Sugar Fast / Random / Post Prandial 
 
2 Urine Test 
 
a. Albumin 
b. Sugar 
c. Deposits 
 
LINE OF TREATMENT 
 
1 To reduce itching and scaling by applying external medicine 
2 Internal medicine  
3 Follow the pathiyam 
 
PROGNOSIS 
 
 The prognosis was noted on the basis of reduction in itching, scaling and erythema. 
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PREPARATION OF TRIAL DRUGS 
 
INTERNAL MEDICINE 
 
Parangipattai Choornam with Sivanaar Vembu Kuzhi Thylam  
 
! “h{<{h<hi!!G]<moliM!gvh<hie!Ohig!
! ! h{<ohie<X!osiz<ZgqOxe<!jlf<ki!OgT!
! f{<{h<hi!hvr<gqBm!hm<jm!uir<gq!
! ! fzlie!hps<six<xqz<!Dxz<!Ohim<M!
! uq{<{h<hi!vuqhmOu!dzxh<!Ohim<M!
! ! uqjsbig!-h<hcOb!hk<KLjx!h{<[!
! k{<{h<hi!fe<xig!dzi<f<k!hqe<H!
! ! kig<gq!fe<xib<!-ck<K!ucg<gm<cmiOb/”!
! ! !
! “gm<migs<!!squeii<!ke<!Oul<jh!uir<gq!
! ! g{<mlkib<!fVg<gqg<!Gpqk<kbqzl<!uir<gq!
! kqm<mlkib<!kbqzikqh<!hm<jmk<!K~Tl<!
! ! Osi<k<K!fe<xib<h<!hqjsf<KVm<c!juk<Kg<!ogi{<M!
! lm<mik!ofz<zqg<gib<!ntU!ogi{<miz<!
! ! lixik!gqvf<kqobiM!$jz!H{<gt<!
! okim<mUme<!YMgqe<x!G]<m!Ovigl<!
! ! osiiq!sqvr<G!ohVR<sqvr<G!-e<er<!OgOt/”!
!
! “Ogith<hi!Olz<Hx<X!ouch<H!ouc!out<jt!
! ! Ogtik!osuqbjmh<H!&g<gjmh<H!
! kith<hi!Olgk<kiz<!uf<kOvigl<!
! ! kVgilOziM!lqVhK!fim<!ogi{<miz<!
! Ogth<hi!ye<xqz<jz!Lh<H,UR<!Osi<k<K!
! ! G{ligg<!ogi{<mUme<!Gcz!fQr<Gl<! !
! fith<hi!fiTg<G!fiOt!Okgl<!!
! ! fe<xigg<!gi[lmi!fle<!fimiOe/”!
                                                          - ng <^kqbi<!nLkgjz!Riel<!!
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PREPARATION OF PARANGIPATTAI CHOORANAM  
 
Ingredients 
           
          Purified Parangipattai 
          Lemon 
 
Purification of Parangipattai  
 
         Parangipattai is purified by boiling in milk till it dries. Then Parangipattai is dried in 
sunlight. 
 
Preparation 
 
                Purified Parangipattai is soaked in lemon juice for 10 days. Everyday new lemon juice 
is used. Then the Parangipattai is dried in sunlight. Dry it for more than 20 days, till it becomes 
ready to powder. Powder the processed Parangipattai and mix it with Sivanaar Vembu Kuzhi 
Thylam. After mixing with Sivanaar Vembu Kuzhi Thylam make it into pills of 1-2 grams 
weight. 
 
DOSE: 1-2 grams  
 
PREPARATION OF SIVANAAR VEMBU KUZHI THYLAM 
 
                 A big pot is filled with the raw drug of Sivanaar Vembu and is sealed with mann 
seelai. It is then allowed to dry. Then the pot is kept in Kuzhi pudam. After cooling Thylam is 
collected from the small pot fixed at the bottom of the big pot. 
 
 
EXTERNAL MEDICINE 
 
PREPARATION OF KODIVELI VER THYLAM 
 
 
ogicOuzq!!Oui<k<jkzl<!
! ! “fblie!ogiMOuzq!hzf<kie<hk<K!
! ! ! fe<xig!uqck<kqm<Mh<!hkg<GfQiqz<!
! ! ublig!ux<xg<gib<f<!okm<omie<xig<gq!
! ! ! utlie!fz<oz{<o{b<!fipquqm<M!%m<c!
! ! fqblig!He<jeg<gib<!ou{<o{b<!)Ohim<M*!
! ! ! fqjzbie!sQvgLl<!hzf<kioeie<X!
! ! o\bl<!ohxOu!bjvk<kkjeh<!higqx<Osi<k<Ks<!
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! ! ! sQvie!olPGhk!lieuiOx/!
! ! Nekbq!zl<uck<K!LPGl<OhiOk!
! ! ! bief<k!uiBuqOei!mef<kl<uib<Uf<!
! ! OkelVUr<!Gpzib<Ogt<!uikk<OkiM!!
! ! ! sqcosiiqBf<!kqeULkx<!sqvr<G!Gm<ml<!
! ! Ohioke<e!ujvbih<Hg<!!gvf<kqS,jz!!
H{<Hjvg!OtiM!ohic!hqtjuuQg<gl<!
! ! fioeeOu!uf<kOfib<!hzUf<kQVl<!
! ! ! fz<zokiV!jkzlqK!fich<hiOv/“!
 
                                                                    -ng <^kqbi<!juk<kqb!h,v{l<!!
  Ingredients 
 
1 Kodiveli Ver  
2 Gingelly Oil 
3 Cuminum Cyminum 
4  Butter 
 
Preparation of Medicine 
 
           KodiveliVer is soaked in 10 Litres of water for one day and the next day the water is 
boiled till it comes to ¼ of its quantity .It is filtered and mixed with one naazhi(1.3litres) of 
Gingelly Oil , one palam (35 grams)ground Cuminum cyminum, and 10 grams butter. Then it is 
boiled till it attains mezhugu consistency. It allowed to cool and is filtered.  
 
USE: External use 
 
 
PROPERTIES OF TRIAL DRUGS 
!
hxr<gqh<hm<jm!)Parangipattai)!
!
 
Botanical Name :  Smilax chinensis  
 
Part Used  : Root tuber 
!
OuX!ohbi<! ! ;!lK <^lqgl<?!lK <^lQgq?!sQeh<hm<jm?!hxr<gqs<sg<jg!
!
Sju! ! ! .!-eqh<H!
ke<jl!! ! .!km<hl<!
hqiqU! ! ! .!-eqh<H!
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“kigl<!hzuikf<!kiKfm<ml<!H{<hqtju!
!! Olgr<!gcgqvf<kq!uQp<&zf<!.!OkgLme<!
!! Gm<jm!hgf<kOlx<!ogit<ulel<!Ohil<hxr<gqh<!
!! hm<jmbqje!Bs<siqk<Kh<!hii<” <!
! ! ! ! ! .Okjvbi<!G{uigml<!
!
wZlqs<sl<!hpl<!)Lemon) 
!
 
Botanical Name : Citrus limon 
 
Part Used  :  Leaf, Fruit,Unripe fruit,Fruit juice, Oil. 
 
Sju! ! ! .!Htqh<H!
ke<jl!! ! .!ouh<hl<! !
osb<jg! ! .!Gtqi<s<sqB{<mig<gq!
hqiqU! ! ! .!gii<h<H! !
!
“kigl<!GfgOfib<!kipis<!sqzqhkOfib<!
!Ougr<ogit<!de<likl<!uQXhqk<kl<!.!lig{<O{ib<!
!ge<eOeib<!uif<kqBl<Ohir<!gm<Mui!kqk<okipqzqz<!
!le<oeZlqs<!sr<geqjb!uip<k<K”!
! ! ! ! ! ! .!ngk<kqbi<!G{uigml<!
!
lbg<gl<?!uif<kq?!de<likl<?!fQi<Oum<jg?!g{<O{ib<!?!giKuzq?!szqhkOfib<!kQVl<!
!
! ogicOuzq!
!
Botanical Name: Plumbago zeylanica 
!
OuX!ohbi<! ;!ou{<sqk<kqv&zl<?!ou{<ogicOuzq!
!
Sju! ! ;!gii<h<H?!uqXuqXh<H!
ke<jl!! ;!ouh<hl<?!
hqiqU! ! ;!gii<h<H!
!
“gm<cuqv!{r<gqvf<K!giz<gt<!!njvbih<Hg<!
! gm<cs<S,!jzuQg<gr<!gip<&zl<!.!Lm<cvk<kg<!
! gm<MfQ!Ovx<xr<!gek<k!ohVubqXl<!
! nm<Mr<!ogicOuzq!bil</”!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!ngk<kqbi<!G{uigml!
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-keiz<! gm<c?! H{<?! gpjz?! utqOfib<?! njvbih<Hg<gm<c?! Osijh?! &zOvigl<?!
dkqvgm<M?!fQOvx<xl<?!ohVubqX!Ohil<!
!
“gm<cOb!!S,jzg<gm<M!gVkqM!Gxqh<H{<!gqvf<kq!
ym<MOl!gv{k<OkiM!LXljv!bih<H!le<xq!
uqm<cmi!ofxqs<!Svl<hqe<!uqbe<uqm!ls<S!vf<kie<!
ohim<omeh<!hxf<K!OhiGl<!Hgp!ogicOuzq!g{<miz<”!!!
!!!!!!!!!!!!!!!!!.!WM!!
Gxqh<H{<!?!gqvf<kq?!njvbih<H, Olgh<H{<?!ofxqSvl<?!fs<Ss<Svl<!LkzqbjuBl<!kQVl</!
!
wt<tqe<!ofb<!)n*!fz<oz{<o{b<!
!
“Hk<kqfbeg<Gtqi<s<sq!H,iqh<H!olb<hHtgR<!
!sk<Kur<!gf<kq!keqbqtjl!.!olk<kU{<mir<!
!g{<O{ib<!osuqOfib<!ghizupz<!gisOfib<!
!H{<O{ib<Ohi!ol{<o{b<bix<!Ohix<X”!
!
!!!!!!Hk<kqg<Gk<! oktqU,! uqpqgTg<Gg<! Gtqi<s<sq?! dmz<! H,iqh<H?! dmz<! ue<jl?!
ngqbux<jxk<! kVuOkiM?! g{<O{ib<?! giK! Ofib<?! kjzg<ogikqh<H?! osixq! sqvr<G?! H{<!
LkzqbjugjtBl<!Ohig<Gl<?!-Vljzk<!k{qg<Gl</!lelgqp<s<sqjbk<!kVl</!
!
sQvgl<!
Botanical Name : Cuminum cyminum 
 
Part Used           : seed. 
!
OuX!ohbi<gt<!!! .!njs?!sQiq?!dhGl<hhQsl<?!fx<sQiq?!Kk<ksil<hzl<?!hqvk<kquqgi?!
!!hqk<kfisqeq?!Ohise!GOmiiq?!Olk<kqbl</!
Sju! ! ! .!gii<h<H!?!-eqh<H!
ke<jl!! ! .!km<hl<!
hqiqU! ! ! .!-eqh<H!
!
!!!!!“hqk<kolE!lf<kqiqjbh<!hqe<eh<!hMk<kqbue<!
! sk<KVju!Bf<Kxf<K!sikqk<K!.!lk<koeEl<!
! visjeB!lQoue<X!f{<jhh<!hzh<hMk<kq!
! OhiseG!miiqosBl<!Ohii</”!
!!!!!!!!!!!!!!!!!!!!!!!!!.!Okve<!ou{<hi!
!
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ou{<o{b<!
!
“ou{<o{jb!B{<cm!uqf<Kjuh<!ohVg<gqOlx<!
x{<o{e!olb<uzq!keg<Gv!liGOl“!
!
! ou{<o{jb! d{<miz<! kiKuqi<k<kqjbBl<?! Okgk<kqx<Gg<! Gtqi<s<sqjbBl<?!
hzk<jkbl<!d{<Mh{<[l</!
!
hS!ou{<o{b<g<!G{l<!
!
“g{<{q!ozPOfiBr<!g{<o{iqUl<!hQjtBl<Ohi!
ol{<[l<!hsqB!olPl<Hr<gi{<!.!f{<{iqb!
NuqeXl<!ou{<o{b<g<!ggZl<ue<!Olgolz<zil<!
H,uqei<g!ogz<zil<!Hgz<“!
!
! hSuqe<! ou{<j{biz<! g{<O{ib<?! g{<o{iqs<sz<?! hQjt! sivz<?! hqvOlgl<! Ohil<?!
hsqB{<mil</!
!
squeii<!Oul<H!
Botanical Name : Indigofera aspalathoides 
 
Part Used  : Leaf, Flower, Stem, Root. 
 
OuX!ohbi<! ! .!gif<kiiq!
Sju! ! ! .!jgh<H!
ke<jl! !!!!!.!ouh<hl<! !
hqiqU! ! ! .!gii<h<H!!
!
“Gm<mR<!sqvr<G!Gjxh<Hh<!hqslif<jk!
gm<mh<!hq{qgt<!gpZOl!.!kqm<ml<!
dveql<hr<!gibk<Kg<!G{<miG!Oljz!
nveql<h!ole<ElVf<!kiz<” 
!!!!!!!!!!!!!!!!!!!!!!!!!.!Okve<!ou{<hi!
!!!!!!squeii<! Oul<hiz<! Okijzh<hx<xq! uVl<! hjmgt<?! fim<hm<m! H{<?! osixq! sqvr<G?!
hqtju?!GjxOfib<?!-jvh<H?!dh<hqsl<?!djtlif<jk!Lkzqbe!Ohil</!
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!
“sib<g<Glqch<!H{<hpl<H{<!si<lGm<!ml<hqtju!
kQg<gMgiz<!ue<ohVOfib<!sqf<Kli!.!Ofib<g<G!
uqjkbikq!Oul<hqei!olb<g<gpG!gijz!!
djkbikq!Oul<hqei!Ze</” 
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                 Parangipattai choornam                                 Sivanaar Vembu Kuzhi Thylam 
  
  
 
 
 
 
 
 
 
  
  
 
                     Parangipattai choornam &  Sivanaar Vembu Kuzhi Thylam 
  Mathirai                         
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RESULTS AND OBSERVATIONS 
 
  
 
AGE  
 
 
Age group 
 
No. of cases Percentage 
0-10 3 10 
11-20 2 6.67 
21-30 3 10 
31-40 9 30 
41-50 5 16.67 
51-60 8 26.67 
Total 30 100 
 
 
 
Among the selected 30 cases most of the cases were in age group 30-40. 
 
 
 
SEX 
                  
 
Sex 
 
No. of cases Percentage 
Male 19 63.33 
Female 8 26.67 
Children 3 10 
Total 30 100 
 
Among the selected 30 cases, the prevalence of the disease was found to be                 
higher in male gender. 
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OCCUPATION 
 
 
                             
 
Occupation  
 
No. of cases Percentage 
Painter 2 6.67 
Cooli 9 30 
Clerk 3 10 
Business 2 6.67 
House Wife 4 13.33 
Children 3 10 
Software 2 6.67 
Students 5 16.67 
Total 30 100 
 
 
 
 
 
FAMILY HISTORY 
 
 
 
 
Family History 
 
No. of cases Percentage 
Yes 4 13.33 
No 26 86.67 
Total 30 100 
 
Most of cases have no family history. 
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 FOOD HABITS 
 
 
 
Food Habits 
 
No. of cases Percentage 
Vegetarian 4 13.33 
Non - Vegetarian 26 86.67 
Total 30 100 
 
 
Among the selected 30 cases, most of cases have non vegetarian food habits 
 
OTHER HABITS 
 
 
Habits 
 
No. of cases Percentage 
Smoking 4 13.33 
Alcohol 7 23.33 
Snuff 2 6.67 
No bad habits 17 56.67 
Total 30 100 
 
                                     
 SOCIO ECONOMIC STATUS 
 
 
Status 
 
No. of cases Percentage 
Poor 20 66.67 
Middle 8 26.67 
Rich 2 6.67 
Total 30 100 
 
Among the selected 30 cases, most of the cases were below poverty line. 
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UDALTHATHUKKAL 
 
 
 
Udalthathukkal 
 
No. of cases Percentage 
Saaram 30 100 
Chenneer 6 20 
Oon - - 
Kozhuppu - - 
Moolai - - 
Sukkilam/Suronitham - - 
 
                                               
Out of 30 cases observed Saaram was affected in almost all cases and Chenneer was affected in 6 
cases. 
 
 ENVAGAI THERVUGAL  
 
Sl.No. 
Type of 
investigations 
No. of cases Percentage 
1. Naa 9 30 
2. Niram 30 100 
3. Mozhi - - 
4. Vizhi 2 6.67 
5. Malam 4 13.33 
6. Moothiram - - 
7. Sparisam 30 100 
8 Naadi - - 
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NAADI 
 
 
Naadi 
 
No. of cases Percentage 
Vadhapitham 17 56.67 
Vadhakabam 3 10 
Pithavadham 2 6.67 
Pithakabam 1 3.33 
Kabavadham 2 6.67 
Kabapitham 5 16.67 
 
 
 
DURATION OF ILLNESS 
 
 
 
 
Duration 
 
No. of cases Percentage 
Up to 6 months 4 13.33 
7 months to 1 yr 2 6.67 
1 yr- 2yrs 1 3.33 
2yrs-3yrs 1 3.33 
More than 3 yrs 22 73.33 
Total 30 100 
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CLINICAL FEATURES  
 
 
 
 
 
Signs & Symptoms 
Before Treatment After Treatment 
No. of 
cases Percentage 
No. of 
cases 
Percentage 
 
Itching 26 86.67 - - 
Scaling 30 100 - - 
Erythema 26 86.67 - - 
Cracks 23 76.67 - - 
Burning sensation 14 46.67 - - 
Cold Intolerance 13 43.33 - - 
Sleeplessness 16 53.33 - - 
Hyperpigmentation 30 100 9 30 
Thickening of skin 30 100 6 20 
Malaise 21 70 - - 
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RESULT 
 
 
 
Improvement 
 
No. of cases Percentage 
Good 20 66.67 
Moderate 7 23.33 
Mild 3 10 
No Change 0 0 
Total 30 100 
 
 
 
 
 
 
 
 
                      
 
Results of Clinical Trials
67%
23%
10%
0%
Good Moderate Mild No Change
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BLOOD INVESTIGATIONS BEFORE TREATMENT 
Sl.no 
 
I.P / OP 
No 
 
Hb 
gm% 
 
TC 
Cells/cu.mm
 
 
DC 
 
ESR Blood 
Urea 
mg/dl 
Serum 
Creatinine 
mg/dl 
Blood Sugar Blood 
Cholesterol 
mg/dl  P%
 
L% E% M% 
½ 
hr 
mm 
1hr 
mm 
F 
mg/dl 
R 
mg/dl 
1 AD7856 13.5 7,100 53 42 3 2 8 18 18 0.6 - - 
2 AD9929 7.2 6,800 50 48 2 - 15 32 20 0.6 - 77 - 
3 AF8710 11.7 6,200 50 46 4 - 12 25 33 0.8 - 100 207 
4 AD9930 12.1 6,100 54 40 4 2 6 12 20 0.6 - - - 
5 AE4573 14.5 7,200 53 45 2 - 2 6 24 0.8 66 - - 
6 AF2064 9.8 7,400 50 44 6 - 16 32 18 0.8 84 - 167 
7 X9534 11 6,400 50 44 2 4 11 22 14 0.8 97 - 186 
8 AG2642 13.1 7,500 54 42 4 - 2 4 20 0.8 85 - 175 
9 D4931 13 7,600 53 41 6 - 14 28 18 0.6 - 111 150 
10 AB4769 9.8 7,200 60 35 3 2 4 8 32 1.1 95 - 185 
11 AG6528 12.5 7,400 59 39 5 - 4 8 30 0.6 66 - 195 
12 Y1444 11 6,500 57 37 4 2 6 12 24 1.2 - 90 172 
13 AD981 11.8 8,000 54 40 4 2 4 8 30 0.8 68 - 189 
14 AG6764 15 7,400 54 42 2 2 2 4 22 0.8 80 - 185 
15 AH9248 14 7,800 53 41 6 - 4 8 24 0.6 81 - 160 
16 AB2114 12 8,000 54 40 3 3 26 50 41 1.2 87 - 167 
17 AF4010 15 8,400 60 34 6 - 12 24 33 0.8 - 91 168 
18 AF1030 10.2 7,000 56 40 4 - 14 28 20 0.6 84 - 148 
19 AE798 13.7 7,000 59 36 5 - 4 8 16 0.5 86 - 129 
20 AI1417 11 6,900 63 32 5 - 4 8 28 1.4 92 - 140 
21 E6215 12 7,500 62 31 7 - 14 28 21 0.6 103 142 
22 1112 10 6,900 55 41 4 - 10 20 29 0.7 - 101 143 
23 591 9.8 8,000 53 43 3 1 20 40 18 0.6 74 - 156 
24 829 11.6 7,900 53 41 6 - 14 28 46 1.4 93 - 141 
25 757 12.6 5,200 52 46 2 - 2 5 28 0.8 75 - 167 
26 840 12.5 8,400 51 39 10 - 28 56 28 1.1 78 - 185 
27 1197 15 8,600 54 40 4 1 10 20 21 0.8 61 - 168 
28 873 12.6 7,400 53 42 3 - 4 8 35 1.2 106 - 170 
29 1044 13.1 7,200 52 46 2 - 4 10 27 0.8 181 - 180 
30 1060 12.6 6,200 50 46 4 - 12 24 20 0.6 - - - 
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BLOOD INVESTIGATIONS AFTER TREATMENT 
Sl.no 
 
I.P / OP 
No 
 
Hb 
gm% 
 
TC 
Cells/cu.mm
 
 
DC 
 
ESR Blood 
Urea 
mg/dl 
Serum 
Creatinine 
mg/dl 
Blood Sugar Blood 
Cholesterol 
mg/dl  P%
 
L% E% M% 
½ 
hr 
mm 
1hr 
mm 
F 
mg/dl 
R 
mg/dl 
1 AD7856 14 6,800 50 46 04 - 4 8 18 0.6 - - - 
2 AD9929 10.5 7,200 53 42 005 - 6 12 18 0.6 - 70 - 
3 AF8710 12.4 8,900 50 46 04 - 4 8 28 0.6 - 110 190 
4 AD9930 - - - - - - - - - - - - - 
5 AE4573 13.2 7,000 58 37 05 - 6 80 12 0.8 - 165 172 
6 AF2064 11 6,400 50 44 04 02 11 22 14 0.8 - 97 186 
7 X9534 12 7,000 53 42 04 01 6 12 14 0.8 - 108 170 
8 AG2642 13.7 7,800 58 40 02 - 2 4 21 0.8 80 - 184 
9 D4931 13.4 8,100 60 38 02 - 4 8 16 0.8 84 - 164 
10 AB4769 9.1 6,800 53 42 05 - 34 70 35 1.3 112 - 200 
11 AG6528 12.8 6,900 54 42 04 - 4 8 26 0.6 71 - 200 
12 Y1444 12.4 7,400 54 42 02 02 6 12 22 0.8 - 101 180 
13 AD981 10.6 7,800 52 46 02 - 4 8 28 0.8 70 - 180 
14 AG6764 14 7,200 60 38 02 - 2 4 30 0.8 85 - 175 
15 AH9248 12 7,400 54 42 04 - 4 8 24 0.6 96 - 168 
16 AB2114 13.6 8,000 50 46 03 01 12 24 30 0.8 90 - 170 
17 AF4010 14.5 8,000 54 42 04 - 4 8 26 0.8 74 - 180 
18 AF1030 11 6,700 53 43 02 - 4 12 22 0.6 80 - 140 
19 AE798 12.6 6,900 50 44 06 - 6 4 16 0.6 100 - 146 
20 AI1417 11.6 7,600 60 32 08 - 2 12 22 1.1 - 98 152 
21 E6215 12.6 7,800 57 38 06 - 6 12 28 0.6 - 112 151 
22 1112 10.5 6,800 50 42 08 - 6 14 24 0.8 63 - 160 
23 591 12.6 7,900 54 41 03 02 40 10 23 0.8 65 - 222 
24 829 10 8,400 54 44 02 - 4 24 16 0.8 81 - 176 
25 757 10.6 7,000 48 48 04 - 12 12 14 0.6 - 96 170 
26 840 12.4 8,900 50 46 04 - 64 8 28 1.0 70 - 184 
27 1197 14.5 8,.000 54 40 04 - 6 12 24 0.8 68 - 170 
28 873 12.8 6,700 53 42 05 - 4 8 18 1.2 71 - 146 
29 1044 13.5 7,200 51 47 02 - 6 12 33 0.8 131 - 160 
30 1060 13 6,000 52 44 04 - 12 24 18 0.6 - - - 
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URINE ANALYSIS 
 
S.No IP /OP No Before Treatment After Treatment Albumin Sugar Deposits Albumin Sugar Deposits 
1 AD7856 Nil Nil 1-2 pus cells, 2-4  epi cells Nil Nil 2-4pus cells, 2-4  epi cells 
2 AD9929 Nil Nil 3-4 pus cells ,2-3  epi cells Nil Nil 1-2pus cells, 2-4   epi cells 
3 AF8710 Nil Nil 2-4 pus cells ,2-4  epi cells Nil Nil 2-3pus cells, 2-4 epi cells 
4 AD9930 Nil Nil 1-2 pus cells ,2-4  epi cells Nil Nil      1-2 pus cells, 1-2 epi cells  
5 AE4573 Nil Nil 4-6pus cells, 2-4  epi cells Nil Nil 2-4pus cells, 1-2  epi cells 
6 AF2064 Nil Nil 6-8pus cells, 6-8  epi cells Nil Nil 1-2pus cells, 1-2    epi cells 
7 X9534 Nil Nil 1-2pus cells, 1-2  epi cells Nil Nil 2-4pus cells, 2-4  epi cells 
8 AG2642 Nil Nil 2-4pus cells, 2-4  epi cells Nil Nil 3-6pus cells, 3-6   epi cells 
9 D4931 Nil Nil 4-6pus cells, 4-6  epi cells Nil Nil 2-3pus cells ,3-6 epi cells 
10 AB4769 Nil Nil 1-2pus cells ,0-1 epi cells Nil Nil 2-3pus cells, 2-3   epi cells 
11 AG6528 Nil Nil 1-2pus cells, 2-4   epi cells Nil Nil 3-6pus cells, 2-4   epi cells 
12 Y1444 Nil Nil 2-3pus cells, 1-2 epi cells Nil Nil 1-2pus cells, 1-2   epi cells 
13 AD981 Nil Nil 4-6pus cells, 4-6   epi cells Nil Nil 2-4pus cells,4-6 epi cells 
14 AG6764 Nil Nil 1-2pus cells, 2-4   epi cells Nil Nil 2-4pus cells,2-4 epi cells 
15 AH9248 Nil Nil 2-4pus cells,6-8   epi cells Nil Nil 4-6pus cells,4-6   epi cells 
16 AB2114 Nil Nil 6-8pus cells, 7-12  epi cells Nil Nil 3-4pus cells, 2-4  epi cells 
17 AF4010 Nil Nil 1-2pus cells, 2-3  epi cells Nil Nil 2-4pus cells, 1-2  epi cells 
18 AF1030 Nil Nil 3-5pus cells, 2-5    epi cells Nil Nil 1-2pus cells, 1-2  epi cells 
19 AE798 Nil Nil 1-2pus cells, 2-4  epi cells Nil Nil 1-2pus cells, 2-4  epi cells 
20 AI1417 Nil Nil 2-4pus cells, 4-6  epi cells Nil Nil 4-6pus cells, 6-8  epi cells 
21 E6215 Nil Nil 0-1pus cells, 1-2  epi cells Nil Nil 3-4pus cells, 2-4 epi cells 
22 1112 Nil Nil 3-4 pus cells, 1-2  epi cells Nil Nil 2-4pus cells, 1-2   epi cells 
23 591 Nil Nil 5-6pus cells, 6-8  epi cells Nil Nil 4-6pus cells, 4-6  epi cells 
24 829 Nil Nil 8-10pus cells, 4-6 epi cells Nil Nil 5-4pus cells, 5-6   epi cells 
25 757 Nil Nil 4-6pus cells, 4-6  epi cells Nil Nil 2-3pus cells, 1-2  epi cells 
26 840 Nil Nil 2-3pus cells, 1-2  epi cells Nil Nil 2-3pus cells, 1-2 epi cells 
27 1197 Nil Nil 2-4pus cells, 2-4   epi cells Nil Nil 2-3pus cells, 2-4  epi cells 
28 873 Nil Nil 2-4pus cells, 4-6  epi cells Nil Nil 1-2pus cells, 2-4 epi cells 
29 1044 Nil Nil 4-6pus cells , plenty of  epi cells Nil Nil 2-4pus cells, 2-4  epi cells 
30 1060 Nil Nil 3-4pus cells, 1-2 epi cells Nil Nil 2-4pus cells, 3-4   epi cells 
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Before treatment 
 
 
 
 
 
 
 
 
 
After treatment 
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After treatment 
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DISSCUSSION 
 
         It is quite common to see skin diseases in day- to-day practice. Even though the aetiology 
of the skin disease is multifactorial, pollution and chemicals will be the commonest cause for the 
majority of cases. 
               
        Etiology, Pathology, Classification, Clinical features, Diagnosis, Complications, Treatment, 
was collected from various numbers of literatures. 
 
DEMOGRAPHY 
 
Age distribution 
          
 This study shows the highest incidence of Virpodaga Kuttam is between 30-40 years 
 
Gender distribution  
           
Out of 30 cases, 19 cases were males, 8 cases were females and 3 cases were children.  
 
Socio economic status 
                 
66.67 % of Virpodaga Kuttam cases belong to low Socio economic status and the rest to 
middle and high class status. 
 
Occupational status  
             Out of 30 cases observed majority of cases (30 %) were working as farmers. This study 
shows that pollution and chemical exposure was one of the causes for this disease.  
 
Family history 
                
Out of 30 cases observed only 4 cases had relevant family history.  
 
Diet habits 
              
Among the 30 cases observed majority of cases (86.67 %) were non-vegetarians. This 
shows that non- vegetarian food items may be a precipitating factor for Virpodaga Kuttam.  
 
Duration of illness before treatment 
           
Out of 30 cases observed 22 cases (73.33%) had illness more than 3 yrs, and also 
majority of cases had reoccurrence history.  
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CLINICAL FEATURES  
 
          Symptoms like itching, scaling and hyperpigmentation present in all the 30 cases (100%). 
Majority of cases had erythema, cracks etc.   
 
Disturbances in Vadham 
 
             Out of 30 cases observed Viyanan and Samanan were affected in almost all the cases  
 
Disturbances in Pitham  
 
          Out of 30 cases observed Prasaga Pitham was affected in almost all cases. 
 
Disturbances in Kabam 
 
Out of 30 cases observed “Santhigam” was affected in 8 cases.  
 
Udal Thaathukkal 
 
               In all the 30 cases (100%), saaram was affected that produced symptoms like lethargy 
and mental depression.   
         Chenneer was affected in 6 cases (20 %) that produced symptoms of anemia 
          
Enbu was affected in 8 cases (26.67 %) that produced symptoms like pain in joints, 
stiffness and deformity.  
 
Envagai Thervugal 
     
Among the 30 cases Naa was affected in 9 cases and it showed pallor and coated tongue. 
Niram was affected in all the 30 cases, e.g. hyper pigmentation, red colored erythema. In sparism 
examination, all the 30 cases showed roughness and warm.  
 
Naadi  
      
Naadi was noted all the 30 cases  
 
Vadhapitham was observed in 17 cases 
                     Vadhakabam was observed in 3 cases  
                     Kabapitham was observed in 5 cases  
                     Pithavadham was observed in 2 cases. 
                     Kabavadham was observed in 2 cases  
                    Pithakabam was observed in 1 case.  
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PURIFICATION OF DRUGS 
 
       All the drugs used for therapeutic purpose were purified by the purification process 
mentioned in the literature. 
 
STUDY OF PHARMACOLOGICAL ACTION OF THE TRIAL DRUGS  
 
 Anti-inflammatory, anti-histamine and acute toxicity of the trial drug was done in 
MOHAMED SATHAK A. J. COLLEGE OF PHARMACY, Medavakkam road, Chennai. 
 
TREATMENT  
           
The treatment was aimed at reducing the symptoms like itching, scaling, and Erythema 
and normalizing the deranged thodams. 
 
• Purgative medicine was given to the patient on the first day of admission to the 
trial. 
• Author treated the patients with trial drugs Parangipattai choornam and 
Sivanaarvembu Kuzhi Thylam (Internal medicine) and Kodiveli Ver Thylam 
(External medicine). 
• During the period of treatment patients were advised to follow the pathiyam. 
(Avoid tamarind, chicken, mutton, pork, sea foods, brinjal). 
              
 - 56 - 
SUMMARY  
 
                Based on Yugi 800, 30 cases of Virpodaga Kuttam was diagnosed clinically and 21 of 
them were admitted and treated with the trial drugs in the OUT patient department of Sirappu 
Maruthuvam and rest of the patients (9 cases) were treated in IN patient department of Sirappu 
Maruthuvam of Ayothidoss Pandithar Hospital attached to National Institute of Siddha, 
Tambaram Sanatorium, Chennai- 47.  
              
  The various Siddha methods of examination of the disease were carried out and the data 
was recorded 
.  
              Before starting the treatment careful history taking was done and recorded.  
 
             During the period of treatment all the patients were put under Pathiyam.  
 
             The observation made during the clinical study shows that the internal drug 
Parangipattai choornam and Sivanaarvembu Kuzhi Thylam and the external medicine Kodiveli 
Ver Thylam are clinically effective.  
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CONCLUSION      
 
• The clinical study confirms the efficacy of the trial drugs by reducing                       
     Itching, scaling and hyperpigmentation. 
• The trial drugs had adequate pharmacological action. 
 
• The trial drugs were simple to prepare and free from side effects. 
 
RESULTS       
 
   Good improvement    :  20 
   Moderate                    : 07 
   Mild                            : 03 
 No Change   : 00 
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ANNEXURE - I 
 
 
PHARMACOLOGICAL STUDY OF TRIAL DRUG 
 
ACUTE ORAL TOXICITY STUDY  
 
          The procedure was followed by using OECD 423 guidelines (Organization of Economic 
Co-operation and Development) (Acute Toxic class method). The acute toxic class method is a 
stepwise procedure with 3 animals of a single sex per step. Depending on the mortality and/or 
moribund status of the animals, on the average 2-4 steps may be necessary to allow judgment on 
the acute toxicity of the test substances. This procedure results in the use of a minimal number of 
animals while allowing for acceptable data-band scientific conclusion. 
 
           The method used defined doses (5, 50, 300, 2000 mg/kg body weight) and the results 
allow a substance to be ranked and classified according to the Globally Harmonized System 
(GHS) for the classification of chemical, which causes acute toxicity. 
 
 
           Six female Wistar rats weighing between 180-250 gm were used for study. The starting 
dose level of Parangipattai Chooranam was 2000 mg/kg body weight p.o as most of the crude 
extracts possess LD50 value more than 2000 mg/kg in b.w.p.o. So 2000 mg/kg was used as 
starting dose. Dose was administered to the rats, which were fasted over night with water ad 
libitum and food were withheld for a futher 3-4 hours after administration (p.o) of drugs and 
observed for signs of toxicity. The same dose was once again tried with another three rats and 
observed for signs of toxicity.  
 
          Body weight of the rats before and after treatment were noted and any changes in skin and 
fur, eyes and mucous membranes and also respiratory, circulatory, autonomic, central nervous 
system, somatomotor activity and behavior pattern were observed and also signs of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma were noted. 
 
Results 
 
         Parangipattai Chooranam at the dose of 2000 mg/kg b.w administered orally not exhibited 
any mortality and morbidity. 
 
Reference  
 
          Ecobichnon DJ, the basis of Toxicity testing 2nd edition, New York, CRC Press, 1997, p-
43. 
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ANTI - HISTAMINE ACTION 
 
Effect of Parangipattai Choornam on Histamine induced bronchospasm in guinea pigs.  
 
 
       Effect of Parangipattai Choornam on histamine induced bronchospasm was studied 
in guinea pigs. Guinea pigs of either sex (400-600 mg) were housed under uniform 
environmental conditions. They were divided into four groups of six animals each, and the 
following regimen of treatment was followed.  
 
Group- I      Animals received 155 mg/kg, p.o of Parangipattai Chooranam, suspended           
with 1% SCMC (sodium carboxy methyl cellulose) administered daily for     seven 
days.  
  
Group- II     Animals received 2 mg/kg,p.o of chlorphenaramine melate, suspended      
with 1% SCMC (sodium carboxy methyl cellulose) administered daily for     seven 
days.  
 
Procedure:  
 
         Prior to drug treatments, the animals were placed in the histamine chamber and exposed to 
micro aerosol of histamine acid phosphate (1%w/v) using a nebulizer under constant pressure of 
40 mm/Hg. The animals exposed to the asthmatic agents showed progressive dyspnoea. The end 
point pre-convulsive dyspnoea (PCD) was determined from the time of aerosol exposure to the 
onset of dyspnoea leading to the appearance of the convulsion. As soon as PCD was noted, the 
animals were removed from the chamber and placed in fresh air. 0-day values PCD was taken 
before treatment. The animals were administered with the Parangipattai Chooranam. On seventh 
day two hours after the last dose, the time for the onset of PCD was recorded as on day 0. The 
animals with stood exposure to histamine aerosols for 10 mins were considered to be completely 
protected. 
 
 
The protection offered by the treatment was calculated by the following formulae,  
 
Percentage protection = {1-T1/T2} X100 
 
Where, 
 
 T1 is time for PCD onset on day 0. 
 T2 is time for PCD onset on day 7. 
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Group 
 
Time of pre- convulsive dyspnoea (sec)  
Percentage 
protection Before treatment After treatment 
I 124.5 ± 4.39 248.3 ±46.07* 49.85 
II 128.0 ± 5.07 453.4 ± 29.30* 71.76 
. 
 
Values are mean ± SEM of six animals in each group. 
 *P< 0.05, after treatment compared with before treatment.  
 
Results 
 
             Parangipattai Chooranam at the dose of 155 mg/kg administered for animals exhibited 
significant anti histamine activity when compared with before treatment. 
 
Reference  
   
           Mitra S.K, Gopumadavan.S, Venkatarangannan.M, Antarlika.S.D, Antiasthmatic and 
anaphylatic effect of E-721 B,a herbal formulation. Indian J.Pharmacology 1999, 31, 133-137. 
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ANTI – INFLAMMATORY ACTION 
 
Evaluation of anti-inflammatory activity of Parangipattai Chooranam by carrageenan 
induced paw edema model. 
  
    Wistar rats of either sex weighing 180 to 250 gms were divided into four groups of six animals 
each.  
 
Experimental protocol 
 
Animals         : Wistar rats. 
Sex                 : Both 
Weight range                  : 180to 250 gm  
Numbers in each group   : 6 
 
Group-I      –  Control animals received Tween  - 20 orally at the dose of 10 ml/kg,b.w. 
 
Group-II     – Animals received Parangipattai Chooranam orally at the dose of    
                      180 mg/kg,b.w. 
Group-III    -  Animals received standard drug Diclofenac sodium orally at the dose of  
                      5 mg/kg, b.w. 
 
                The paw edema was induced by injection of 0.1ml of 1% carrageenan in 0.9% saline4 
into sub- plantar region of the left hind paw of the rats. The Parangipattai Chooranam, standard 
(Diclofenac sodium 5 mg/kg, b.w) and control (1% SCMC) were administered 60 minutes before 
carrageenan injection. The volume of injected paw was measured at 60 minute, 120 minutes, 180 
minutes, 240 minutes after the carrageenan injection using a plethysmometer and the edema was 
expressed by increase in paw volume. 
 
Group 60 minutes 120 minutes 180 minutes 240 minutes 
I 0.29 ±0.13 0.36±0.05 0.51±0.01 0.50±0.06 
II 0.17±0.04* 0.19±0.06* 0.32±0.03* 0.36±0.03* 
III 0.16±0.05* 0.17±0.08* 0.14±0.04* 0.16±0.08* 
 
Values expressed as mean ±S.D of 6 animals in each group. 
Comparison were made between Group-I vs II and III 
*p<0.05. 
 
Results 
 
      Anti inflammatory activity of Parangipattai Chooranam at the dose of 180 mg/kg was 
significant when compared with control animals.  
 
Reference  
 
Winter C.A, Risley,E.A and NUS, G.N.  
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BIO-CHEMICAL ANALYSIS  
 
Bio-chemical Analysis of trial drug Parangipattai Choornam and Sivanaar Vembu Kuzhi                         
Thylam  
 
Procedure  Observation  Inference  
Test for Calcium: 2ml of 
extract is taken in a clean test 
tube. To this add 2ml of 4% 
ammonium oxide solution. 
No white precipitate is formed Absence of Calcium 
 
Test for Sulphate: 2ml of the 
extract is added to 5% barium 
chloride solution  
No white precipitate is formed Absence of  Sulphate 
Test for Chloride: The 
extract is treated with silver 
nitrate solution.  
White precipitate is formed Presence of  Chloride 
Test for Carbonate: The 
substance is treated with Conc. 
HCL 
No effervescence is formed Absence of  Carbonate  
Test for Starch: The extract is 
added with weak iodine 
solution  
Blue colour is formed Presence of  Starch 
Test for Iron(Ferric): The 
extract is treated with glacial 
acetic acid and potassium 
Ferro cyanide  
No blue colour is formed Absence of  Ferric iron 
Test for  Iron(Ferrous): The 
extract is treated with Conc. 
HNO3  and ammonium 
thiocyanate  
No blood red colour is formed Absence of  Ferrous iron 
Test for Phosphate: The 
extract is treated with 
ammonium molybdate and 
conc. HNO3   
Yellow precipitate is formed  Presence of  Phosphate 
Test for Tannic acid: The 
extract is treated with Ferric 
chloride  
No blue black precipitate is 
formed  
Absence of Tannic acid  
 
Test for saponins: Dilute 
extract with 1ml of distilled 
water and shake well. 
Froth formed  Presence of Saponins  
 
Test for Sugars:           
Benedict method: 5ml of 
Benedict solution heated 
gently then add 8 drops of 
diluted extract then heated in a 
boiling water.                              
Colour change present Indicates presence of sugar 
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Molisch test: Dilute extract 
with 2 drops of Molisch and 
3ml conc.H2SO4 
Reddish violet zones appeared Presence of carbohydrate  
Test for Steroids: Liberman 
Burchard test: Dilute extract 
with 2ml acetic anhydride and 
conc. H2SO4 
Formation of red colour  Presence of steroids 
Test for amino acids: Dilute 
extract with 2 ml of 
Ninhydrin’s solution  
Formation of violet colour Presence of amino acids  
Test for Proteins: Biuret 
method: 1ml of dilute extract 
added with 1ml of 5% CuSo4 
and 1% NaOH.  
Formation of violet colour Presence of proteins   
Test for alkaloids: Mayer’s 
method: 1ml of dilute extract 
is added with 1ml of reagent.  
Appearance of cream colour 
precipitate  
Presence of alkaloids   
Dragendroff’s method: 1ml 
of dilute extract is added with 
1ml of reagent  
Appearance of orange colour 
precipitate 
Presence of alkaloids   
Test for phenol: Dilute 
extract is added with 2 drops 
of FeCl3 solution.  
No formation of deep green 
colour  
Absence of phenol. 
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ANNEXURE - II 
 
PROTOCOL 
 
AN  OPEN PILOT  CLINICAL TRIAL OF SIDDHA DRUGS  PARANGIPATTAI  
CHOORNAM  WITH  SIVANARVEMPU KUZHI THYLAM  AND  KODIVELI VER 
THYLAM  FOR THE  TREATMENT OF VIRPODAGA KUTTAM  
 (EXFOLIATIVE DERMATITIS) 
BY 
 
DR. A. G. SUJITHA, PG STUDENT, DEPT. OF SIRAPPU MARUTHUVAM, NIS, CHENNAI. 
 
1. BACKGROUND 
 
                     Exfoliative dermatitis is a cutaneous syndrome characterized by generalized 
exfoliation and erythema which may be resulting from or be associated with pre-existing skin 
conditions, systemic diseases or drug reactions. It is a rare disease. Its prevalence being 71 per 
100,000 dermatological patients.  
 
                     In Eugi 800 text Virpodaga kuttam has been described as,   
 
!! “HKjlbib<s<!siQvolr<Gf<!kqeU{<!miGl<!!
!!!!! ! ohiVoucbib<k<!kqg<ogek<kQg<!ogiPf<K!Ohiz!!
!! olKjlbib<!uqm<omiqBl<!fz<zhil<hqe<!!
!!!!! ! uq]h<hml<!OhiOz!kck<K!ouTh<H!liGl<!!
!! SKjlbib<lqgs<!osiiqBR<!squh<HliGl<!!
!!!!! ! Kig<goliM!sR<szLl<!lqg!U{<miGl<!!
!! gKjlbib<!Okiozz<zif<!kch<H{<miGl<!!
!!!!! ! gek<kuqx<!Ohimglie!Gm<mf<kiOe!“!
                                                    
                                                                                               
 
                     In Agasthiar Amuthakalai Gnanam and Agasthiar Vaithya Poornam, there is a 
preparation for Virpodaga kuttam, which is not in common practice. So I try to estimate the 
efficacy of this medicine in an open clinical trial in our OPD and IPD patients.  
 
2. AIMS 
 
a) PRIMARY AIM 
 
                    To find out the efficacy of Parangipattai choornam with Sivanarvembu kuzhi thylam 
(Internal) and Kodiveli ver thylam (External) in Virpodaga kuttam patients.  
 
b) SECONDARY AIM  
 
                    To find out the side effects of the drugs, if any. 
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3. POPULATION AND SAMPLE 
 
                  The population consists of all Virpodaga Kuttam patients (erythema, scaling) 
satisfying the inclusion criteria and exclusion criteria mentioned below. The sample consists of 
patients attending the OPD of   Ayothidoss Pandithar Hospital of the National Institute of Siddha, 
Chennai.  
 
4. SAMPLE SIZE 
 
                  The trial size will be 30 patients.  
 
5. SELECTION CRITERIA 
 
 a) INCLUSION CRITERIA  
 
               1. Age upto 60 yrs.  
               2. Willing to give specimen of blood and urine for the investigation when required.  
               3. Willing to be admitted in the Hospital for 40 days or willing to attend the OPD once 
in 7 days for 40 days.  
 
 b) EXCLUSION CRITERIA  
 
                Auto immune disorders like Systemic Lupus Erythematous, Protein deficiency 
malnutrition (Childhood), Icthyosis, Dry skin, Diabetes mellitus, Keratitis, Cardiac diseases or 
any other serious illness.  
 
        
 c) WITHDRAWAL CRITERIA 
 
              1. Any drastic changes occurring in hematological findings.  
              2. Development of any severe irritability.  
              3. Occurrence of any serious illness.  
                                  
6. TRIAL DRUG, DOSAGE AND DURATION  
               
             INTERNAL MEDICINE:  Parangipattai Choornam with Sivanarvempu Kuzhi     
 Thylam, twice in a day, after food with hot water. 
                                                         Dosage: Children below 14years - 1 gram. 
                                                                       Adult 14 + years             - 2 grams.  
 
            EXTERNAL MEDICINE:  Kodiveli Ver Thylam.  
 15 ml, applied twice a day.  
 
           TRIAL PERIOD               :   40 days.                         
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!
7. ASSESSMENT AND TESTS 
 
             a) CLINICAL ASSESSMENT  
 
                     - Erythema, Pruritis, Chilly sensation (shivering), Scaling, Nails – Ridged, 
Thickened and also may be shed.                                          
         
           b) INVESTIGATIONS  
                   
                        Blood test  
Hb, TC, DC, ESR, CRP, Serum albumin, Serum creatinine, Blood Sugar-F, 
PP.   
                        Urine test 
                        Albumin, Sugar, Deposits.                                                                                                  
  Motion test 
                   Ova, Cyst, RBC.            
                 Siddha Assessment  
                                   Envagai thervu, Udarthathukkal, Neerkuri, Neikuri.  
  
8. CONDUCT 
                   
                   Virpodaga Kuttam patients satisfying the inclusion and exclusion criteria will be 
eligible for admission to the trial.Consent will be obtained from the patients.  
                  A day before starting the trial treatment cleaning of mukkutras by purgation (14 ml of 
Karudan Kizhangu Ennai) will be carried out. In case of children age below 5years purgation is 
not used.  
                                                             
           The trial drug will be issued to the OPD patients for 7 days at a time and the patients will 
be asked to bring back the unconsumed drugs at each visit and return them. Patients are asked to 
come for clinical assessments once in 7 days for 40 days. At each visit, a new drug container will 
be issued to the patients. 
                   Photos will be taken and lab tests will be carried out before treatment and at the end 
of the treatment.  
 
9. FORMS 
 
               a) FORM 1 – Selection proforma  
                          It is used before admission of the patients to the trial. 
 
              b)  FORM 11 – Assessment form  
                           It is used once in 7 days for 40 days.  
 
10. ANALYSIS 
  
                        Reduction in the proportion of the patients with signs and symptoms before and 
after treatment will be analyzed by using paired X2 –test  
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AN  OPEN PILOT  CLINICAL TRIAL OF SIDDHA DRUGS  PARANGIPATTAI  
CHOORNAM  WITH  SIVANARVEMPU KUZHI THYLAM  AND  KODIVELI VER 
THYLAM  FOR THE  TREATMENT OF VIRPODAGA KUTTAM  (EXFOLIATIVE 
DERMATITIS ) 
FORM-I   SELECTION PROFORMA 
 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________ 3. S.No: ________    
 
4. Name: ________________ 5. Age (years):        6. Gender: Male/Female  
 
7. Occupation: ____________________  8. Income: ____________________ 
 
9. Address:  
  
 
                                                              
10. Complaints and duration:  
 
 
 
11. History of present illness:  
 
 
  
12. Past history:  
 
 
 
  13. Family history:  
 
 
    
Habits                                          Yes (1)            No (2) 
 
14. Smoker                                      
 
15. Alcoholic                   
 
16. Betal Nut chewer              
 
17. Drug Addiction   
                   
18. Non-vegetarian:  
 
 - 68 - 
GENERAL EXAMINATION 
 
 
19. Weight (kg):                                                    
        
20. Temperature (°F):        . 
  
21. Pulse rate / minute:                                          
 
22. Heart rate / minute:        
 
23. Respiratory rate / minute:                              
   
24. Blood pressure (mmHg):                               /       / 
 
                                                      1. Yes                    2.No            
25. Pallor:                                 
 
26. Jaundice:                       
 
27. Cyanosis:  
           
28. Lymphadenopathy:  
  
29. Pedal oedema:  
  
30. Clubbing:                                
 
31. Jugular vein pulsation:            
 
32. Congenital Abnormalities     
 
33. Engorged Vein 
 
 
    CLINICAL EXAMINATION OF SKIN 
 
     
 
   1. Yes                  2.No 
 
34. Erythema  
 
35. Itching 
 
    
36. Scaling  
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37. Malaise 
 
38. Chilly sensation 
 
39. Pigmentation             Hyper   Hypo 
    
 NAILS  
 
40. Ridged 
        
41. Thickened 
 
PERIORBITAL SKIN 
   
42.Inflammed 
 
43. Edematous 
 
 
EXAMINATION OF OTHER SYSTEMS 
 
                                               1. Normal         2. Affected 
 
44. CVS                                                                                  __________________ 
       
45. RS                                                                   _                ________________ 
 
46. CNS                                                   __________________ 
 
47. RENAL SYSTEM                      ________________ 
   
48. ENDOCRINE SYSTEM                                  __________________ 
 
49. NERVOUS SYSTEM                              __________________ 
 
 
  SIDDHA SYSTEM OF EXAMINATONS 
 
50. THINAI 
      1. Kurunji           2. Mullai                3. Marutham     
 
      4. Neithal                5. Palai  
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 51. KAALA IYALBU 
 
 
     1. Elavenil kalam         2.Muthuvenil kalam 
  
     3. Kaar kalam             4. Koothir kalam  
  
   5. Munpani kalam             6. Pinpani kalam     
 
52. YAAKKAI 
  1. Vali                   2. Azhal            3. Iyam     
  
    4. Valiazhal       5. Valiaiyam            6. Azhalvali   
    
  7. Azhaliyam     8. Iyavali             9. Iyaazhal  
  
53. GUNAM 
 
    1. Sathuva gunam                  2. Rajo gunam         
 
    3. Tamo gunam 
 
 IYMPORIKAL  
                                      1. Normal        2. Affected 
  
54. Mei                    _____________________ 
 
55. Vaai                     ______________________ 
           
56. Kan              _____________________ 
 
57. Mookku                              _____________________ 
 
58. Sevi                              _____________________ 
    
  
 KANMENTHIRIUM  
   
  
59. Kai                  _____________________ 
 
60. Kaal            _____________________ 
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61. Vaai                _____________________ 
 
62. Eruvai               ____________________ 
    
63. Karuvaai             _____________________ 
 
UYIR THATHUKKAL 
      
  VALI 
    
                                        1. Normal       2. Affected 
 
64. Pranan                                         ____________________ 
 
65. Abanan                                         _____________________ 
 
66. Samanan                                           ____________________ 
 
67. Udhanan                                         _____________________ 
         
68. Viyanan                                          _____________________ 
 
69. Nagan                                         _____________________ 
 
70. Koorman                                           ____________________ 
 
71. Kirukaran                                          ____________________ 
 
72. Devathathan                                       ______________________ 
 
73. Tananjeyan              _____________________ 
  
    
    AZHAL 
                                     1. Normal          2. Affected 
 
74. Anala pittham             ____________________ 
 
75. Prasaka pittham              __________________ 
 
76. Ranjaka pittham                         ______________________ 
 
77. Aalosaka pittham                       ______________________ 
 
78. Saathaka pittham                   ______________________  
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   IYAM 
                                     1. Normal          2. Affected                                     
 
79. Avalambagam           ______________________ 
 
80. Kilethagam                                                           _____________________  
 
81. Pothagam                            ______________________ 
  
82. Tharpagam                  _______________________     
       
83. Santhigam                        ______________________ 
 
        
 UDAL THATHUKKAL 
                                     
      1. Normal         2. Affected 
84. Saaram                   _______________________ 
 
85. Chenneer                                                             _______________________ 
              
86. Oon                           _____________________ 
 
87. Kozhuppu                      _______________________ 
 
88. Enbu                         _______________________ 
     
89. Moolai                                        _______________________ 
 
90. Sukkilam / Suronitham          _______________________ 
         
  
 ENVAGAI THERVUKAL 
 
                                    1. Normal        2. Affected 
91. Naa                                                _____________________ 
     
92. Niram                                            _____________________ 
     
93. Mozhi                                  _____________________ 
 
94. Vizhi                                   ______________________   
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95.  Sparisam:       1.Mithaveppam         2.Miguveppam         
                    
        3. Thatpam 
 
 
 Malam        1. Normal        2. Affected     
 
96.  Niram                       
_ 
97.  Nurai 
                                                                 .     
98.  Karumai  
                                                  
99. Kalappu  
                     
100. Thanmai                      
    
 
 Moothiram    
         
 Neerkuri   
 
 101. Niram                               ______________________ 
     
 102. Eadai                                                _____________________ 
                                
 103. Manam                             ______________________  
 
 104. Nurai                             ______________________ 
  
 105. Enjal                                      ______________________ 
  
 
106.  Neikuri       1.Vatham          2. Pittham         3. Khabam      
     
        
107. Naadi:    1.Vatham        2.Pittham                  3.khabam          
  
     4. Vathapittham             5. Vathakhabam            6. Pitthavatham   
  
     7. Pitthakhabam              8. Khabavatham            9. Khabapittham    
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INVESTIGATIONS        
BLOOD 
108. TC (cells /cumm): 
 
        DC (%):     109.  P                110.  L            111.  E                 112. B                 113. M 
                     
114. Hb (g %):                  . 
 
 ESR (mm/hr):               115.  1/2hr                    116. 1hr 
 
117. Blood Sugar (F) (mg %): 
 
118. Blood Sugar(PP)(mg %): 
 
119. Blood Sugar (R) (mg %) 
 
120. Blood Urea (mg %):     
 
121. Serum Creatinine (mg %):              .  . . 
  
      URINE 
 
122. Albumin:      0. Nil  1. Trace  2. +  3. + + 
  
    4. + + +    
                                                                                                                                    
123. Sugar (F):          0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
 
124. Sugar (PP):        0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
         
 Deposit                                1. Yes          2. No 
 
125. Pus cells                       
 
126. Epithelial cells            
  
127. RBC                                
      
128. Crystals                             
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 MOTION         
              Present (1)       Absent (2) 
129. Ova 
 
130. Cyst 
                                                                                                                                                                        
131. Occult blood  
 
132. Pus cells   
 
 
133. ADMITTED TO TRIAL:     1.Yes          2. No   
 
If yes   
 
134. S. No:    
                 
135. I.P / O.P       1. I.P        2. O.P  
 
136. Drug issued for OP patient (g): 
         
                       1. No .of Tablets  
 
             
                       2. Volume of Thylum 
 
 
 
137. Station                                                                                  139.   Signature of the doctor 
138. Date:                                                                                        
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AN  OPEN PILOT  CLINICAL TRIAL OF SIDDHA DRUGS  PARANGIPATTAI  
CHOORNAM  WITH  SIVANARVEMPU KUZHI THYLAM  AND  KODIVELI VER 
THYLAM  FOR THE  TREATMENT OF VIRPODAGA KUTTAM  (EXFOLIATIVE 
DERMATITIS ) 
FORM-II ASSESSMENT PROFORMA 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________ 3. S.No: ________    
 
4. Name: ________________                        5. Date of Starting Treatment 
  
6. Date of the Assessment   7. Day 
 
CLINICAL EXAMINATION OF SKIN                                                    
   1. Yes                  2.No 
 
8. Erythema  
 
9. Itching 
 
10. Scaling 
 
11. Malaise 
 
12. Chilly sensation 
 
13. Pigmentation             Hyper   Hypo 
    
 NAILS  
14. Ridged 
        
15. Thickened 
 
PERIORBITAL SKIN   
16.Inflammed 
 
17. Edematous 
 
FOR OP PATIENTS   
18. DRUGS ISSUED           1. No. of  tablets                    2. Volume of Thylam   
                
19. DRUGS RETURNED   1. No. of   tablets                    2. Volume of Thylam  
 
Date  
 
Station                                                                                  Signature of doctor 
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LAB INVESTIGATIONS  
BLOOD  
20. TC (cells /cumm): 
 
DC (%):    21. P        22.  L                   23. E   24. B                 25. M 
                     
26. Hb (g %):                 . 
 
ESR (mm/hr):                   27.  1/2hr                      28.1hr 
 
29. Blood Sugar (F) (mg %): 
 
30. Blood Sugar (PP) (mg %): 
 
31. Serum Creatinine (mg %):                   .  
 
 URINE 
 
32. Albumin:    0. Nil             1. Trace  2. +  3. + + 
  
 4. + + +    
33. Sugar(F) :     0. Nil            1. Trace            2. +                3. + +         
 
                         4. + + + 
 
34. Sugar (PP):   0. Nil            1. Trace             2. +  3.         3.  + +         
 
  4. + + + 
   
35. Deposit           1. Yes                    2. No 
 
 MOTION         
                                         Present (1)        Absent (2)   
   
36. Ova  
37. Cyst                                                                                                                                                                        
38. Occult blood 
 
RESULT        Cured                       Improved             No change 
 
             
Date:     
                                                                                            Signature of the Doctor  
Station: 
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